Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$72.30
-3.49-4.6%
Last update: Sep 30, 4:27 PM
$72.30
-3.49-4.6%
GeneDx Holdings Corp (WGS) Stock Price, Quote, News & History
WGSNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of GeneDx Holdings (NASDAQ:WGS) through any online brokerage.
Other companies in GeneDx Holdings’s space includes: CVS Health Corp (NYSE:CVS), The Cigna Group (NYSE:CI), Quest Diagnostics Inc (NYSE:DGX), Labcorp Holdings Inc (NYSE:LH) and Guardant Health Inc (NASDAQ:GH).
GeneDx Holdings has a consensus price target of $87.50.
The stock price for GeneDx Holdings (NASDAQ: WGS) is $72.3 last updated September 30, 2026 at 4:27 PM EDT.
There are no upcoming dividends for GeneDx Holdings.
GeneDx Holdings does not have any upcoming earnings scheduled.
There is no upcoming split for GeneDx Holdings.
GeneDx Holdings is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
